dr. tyna moore glp-1 GLP-1s can change your life... BUT only if you use them correctly. ⠀ In this episode of Between Two Lips, @drtyna explains why many people stall out on GLP-1s Ozempic: A Weight Loss Miracle

Benito-Martn, M.S

Tirzepatide (Mounjaro for T2D, Zepbound for obesity) is a dual GIP and GLP-1 receptor agonist with a similar contraindication profile to semaglutide-based medications

These effects are generally mild and temporary

This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular disease, or CKD [chronic kidney disease], said lead author Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney

Its a trusted choice for maintaining optimal vitality and performance across all animal species.